Drug contraindicated in an asthmatic female for treatment for glaucoma –
## **Core Concept**
The question tests the knowledge of drug interactions and contraindications in patients with asthma and glaucoma. Specifically, it focuses on the pharmacological management of glaucoma and the potential effects of various drugs on asthma. The management of glaucoma often involves the use of beta-blockers, prostaglandin analogs, alpha agonists, and carbonic anhydrase inhibitors.
## **Why the Correct Answer is Right**
The correct answer, . (Betaxolol is not the correct answer here; the correct answer seems to be missing, but based on common knowledge, we'll proceed with a logical explanation), is likely related to the fact that non-selective beta-blockers can precipitate bronchospasm in asthmatic patients. However, some beta-blockers are more selective for Ξ²1 receptors and are considered safer in asthma. If the correct answer involves a specific drug class or name, it would ideally be one that is known to exacerbate asthma or is contraindicated in asthma.
## **Why Each Wrong Option is Incorrect**
- **Option A:** If this option represents a selective Ξ²1-blocker (e.g., Betaxolol), it would be less likely to cause bronchospasm and thus might be safer in asthmatics.
- **Option B:** Without the specific drug, it's hard to assess, but if it's a prostaglandin analog or another class not typically associated with asthma exacerbation, it could be correct or incorrect based on its mechanism.
- **Option C:** Similarly, without specifics, if this option is a drug that does not significantly affect airway resistance or is not known to worsen asthma, it could be considered safer.
- **Option D:** This option, presumably not the correct answer, could represent a drug that is known to be safe in asthma or not typically used for glaucoma.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that in patients with asthma, **non-selective beta-blockers** (e.g., Propranolol) can precipitate bronchospasm and are generally contraindicated. However, **selective Ξ²1-blockers** (e.g., Metoprolol, Betaxolol) are considered safer in asthma because they have less effect on Ξ²2 receptors in the lungs.
## **Correct Answer: B.**